XM无法为美国居民提供服务。

FTSE 100 flat as heavyweights trading ex-div offset gains from GDP data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>FTSE 100 flat as heavyweights trading ex-div offset gains from GDP data</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

FTSE 100 flat, FTSE 250 off 0.2%

Aug 15 (Reuters) -The UK's benchmark index FTSE 100 was flat on Thursday as gains from an in-line UK GDP data, showing a still-healthy economy, were offset by losses in companies that traded without entitlement to their latest dividend payouts.

The bluechip FTSE 100 .FTSE was flat as of 0711 GMT after logging four sessions of gains, while the midcap FTSE 250 .FTMC was down 0.2%.

Britain's economy grew 0.6% in the second quarter of 2024, in line with economists' expectations and building on a rapid 0.7% recovery in the first quarter of the year after a shallow recession in the second half of 2023.

"It's worth noting that June's GDP figure was completely flat, which might initially raise concerns. However, this could actually provide the Bank of England with further justification to consider cutting interest rates next month," said Sam North, market analyst at investment platform eToro.

The pound GBP= was higher against the U.S. dollar and money markets still see a 40% chance of BoE cutting rates by 25 basis points in September. 0#BOEWATCH

Overall, the investor sentiment remained sanguine partly after the benign U.S. consumer inflation data overnight reinforced bets for the Federal Reserve to start cutting interest rates next month.

Among sectors, industrial metal miners .FTNMX551020 slid 1.1%, on track for its third session of declines, as Rio Tinto RIO.L and Anglo American AAL.L traded ex-dividend.

Admiral Group ADML.L jumped 11.6% after the motor and home insurer posted a forecast-beating 32% rise in pre-tax profit for the first half of the year, and said it would pay a special dividend.

Index heavyweight AstraZeneca AZN.L was up 0.8% after the U.S. Food and Drug Administration (FDA) granted its blockbuster cancer drug Imfinzi a priority review for patients with limited-stage small cell lung cancer in the United States.

HSBC HSBA.L, Barclays BARC.L, and Entain ENT.L were among the bottom performers as these companies also traded without entitlement to their latest dividend payouts.






Reporting by Shubham Batra in Bengaluru; Editing by Eileen Soreng

 For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明